Mitsubishi UFJ Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-20,870
| Closed | -$175K | – | 1689 |
|
|
2026
Q1 | $175K | Sell |
20,870
-516
| -2% | -$5.42K | ﹤0.01% | 996 |
|
|
2025
Q4 | $290K | Sell |
21,386
-2,268
| -10% | -$28.3K | ﹤0.01% | 960 |
|
|
2025
Q3 | $228K | Buy |
23,654
+47
| +0.2% | +$416 | ﹤0.01% | 977 |
|
|
2025
Q2 | $194K | Sell |
23,607
-4,149
| -15% | -$34.7K | ﹤0.01% | 979 |
|
|
2025
Q1 | $198K | Buy |
27,756
+2,326
| +9% | +$17.3K | ﹤0.01% | 957 |
|
|
2024
Q4 | $198K | Buy |
25,430
+8,267
| +48% | +$77.6K | ﹤0.01% | 993 |
|
|
2024
Q3 | $180K | Sell |
17,163
-1,619
| -9% | -$19.7K | ﹤0.01% | 975 |
|
|
2024
Q2 | $220K | Buy |
18,782
+7,050
| +60% | +$110K | ﹤0.01% | 954 |
|
|
2024
Q1 | $247K | Sell |
11,732
-538
| -4% | -$9.57K | ﹤0.01% | 939 |
|
|
2023
Q4 | $212K | Sell |
12,270
-2,269
| -16% | -$40K | ﹤0.01% | 1006 |
|
|
2023
Q3 | $239K | Buy |
14,539
+870
| +6% | +$15.8K | ﹤0.01% | 1003 |
|
|
2023
Q2 | $273K | Buy |
13,669
+666
| +5% | +$12.8K | ﹤0.01% | 997 |
|
|
2023
Q1 | $246K | Buy |
13,003
+786
| +6% | +$17.4K | ﹤0.01% | 1007 |
|
|
2022
Q4 | $272K | Sell |
12,217
-602
| -5% | -$13.6K | ﹤0.01% | 989 |
|
|
2022
Q3 | $339K | Buy |
12,819
+216
| +2% | +$6.41K | ﹤0.01% | 961 |
|
|
2022
Q2 | $311K | Buy |
12,603
+2,713
| +27% | +$67.8K | ﹤0.01% | 991 |
|
|
2022
Q1 | $328K | Buy |
9,890
+532
| +6% | +$14.8K | ﹤0.01% | 989 |
|
|
2021
Q4 | $321K | Buy |
9,358
+635
| +7% | +$21.6K | ﹤0.01% | 999 |
|
|
2021
Q3 | $366K | Buy |
8,723
+221
| +3% | +$7.95K | ﹤0.01% | 985 |
|
|
2021
Q2 | $330K | Sell |
8,502
-1,670
| -16% | -$59.7K | ﹤0.01% | 1024 |
|
|
2021
Q1 | $347K | Buy |
10,172
+3,565
| +54% | +$152K | ﹤0.01% | 940 |
|
|
2020
Q4 | $300K | Buy |
6,607
+1,600
| +32% | +$55.9K | ﹤0.01% | 907 |
|
|
2020
Q3 | $138K | Buy |
5,007
+34
| +0.7% | +$1.11K | ﹤0.01% | 934 |
|
|
2020
Q2 | $183K | Buy |
4,973
+305
| +7% | +$11.4K | ﹤0.01% | 904 |
|
|
2020
Q1 | $151K | Buy |
4,668
+905
| +24% | +$37.7K | ﹤0.01% | 886 |
|
|
2019
Q4 | $147K | Buy |
3,763
+271
| +8% | +$10.7K | ﹤0.01% | 916 |
|
|
2019
Q3 | $124K | Buy |
3,492
+686
| +24% | +$27.8K | ﹤0.01% | 881 |
|
|
2019
Q2 | $144K | Buy |
2,806
+212
| +8% | +$10.6K | ﹤0.01% | 873 |
|
|
2019
Q1 | $149K | Buy |
2,594
+225
| +9% | +$11.1K | ﹤0.01% | 835 |
|
|
2018
Q4 | $97K | Sell |
2,369
-339
| -13% | -$19.9K | ﹤0.01% | 857 |
|
|
2018
Q3 | $204K | Buy |
+2,708
| New | +$195K | ﹤0.01% | 773 |
|
Other funds holding RGNX
RG
Mitsubishi UFJ Asset Management's RGNX Position: Q2 2026 in Review
Mitsubishi UFJ Asset Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 20,870 shares — an estimated $175K sold.
Mitsubishi UFJ Asset Management first reported a position in RGNX in Q3 2018 and held it in 31 quarters. The position peaked at $366K in Q3 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Mitsubishi UFJ Asset Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
- Mitsubishi UFJ Asset Management sold 20,870 Regenxbio shares in Q2 2026, an estimated $175K.
- Mitsubishi UFJ Asset Management first reported a position in Regenxbio in Q3 2018 and held it in 31 quarters.
- Mitsubishi UFJ Asset Management's Regenxbio position peaked at $366K in Q3 2021.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.